GoldMiner Search

Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab.
GBCA-enhancing volume on T1-weighted MRI significantly decreased (P=0.005) post-BEV

Fluids Barriers CNS
Copyright © 2018, American Roentgen Ray Society   @ARRS_GoldMiner ARRS GoldMiner® is a registered trademark of the American Roentgen Ray Society.